-
Brunn A A, Teepe C, Simpson J C, et al. 2007. Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome. PLoS ONE, 23: 459.
-
Chang W S, Zhai J, Song W G. 2008. Screen and Identification of The Protein-protein Interactors in The HostCell With The SARS Coronavirus Nucleocapsid Protein. Prog Biochem Biophy, 35 (9): 1007-1013. (in Chinese)
-
Fan Z, Zhou Y, Tan X, et al. 2006. SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. J Med Virol, 78: 1365-1373.
doi: 10.1002/(ISSN)1096-9071
-
Kopecky-Bromberg S A, Martínez-Sobrido L, Frieman M, et al. 2007. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol, 81: 548-557.
doi: 10.1128/JVI.01782-06
-
Lalani A S, Graham K, Mossman K, et al. 1997. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin domains of chemokines. J Virol, 71 (6): 4356-4363.
-
Luo C, Luo H, Zheng S, et al. 2004. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A, Biochem Biophys Res Commun, 321: 557-565.
doi: 10.1016/j.bbrc.2004.07.003
-
Luo H, Chen Q, Chen J, et al. 2005. The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleo-protein A1, FEBS letters, 579: 2623-2628.
doi: 10.1016/j.febslet.2005.03.080
-
Matloubian M, David A, Engel S, et al. 2000.A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol, 1 (4): 298-304.
doi: 10.1038/79738
-
Saikatendu K S, Jeremiah J S, Subramanian V, et al. 2007. Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N Protein. J Virol, 81: 3913-3921.
doi: 10.1128/JVI.02236-06
-
Shashkin P, Simpson D, Mishin V, et al.2003. Expression of CXCL16 in human T cells. Arterioscler Thromb Vasc Biol, 23 (1): 148-149.
doi: 10.1161/01.ATV.0000043906.61088.4B
-
Surjit M, Kumar R, Mishra R N, et al. 2005. The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein Is Phosphorylated and Localizes in the Cytoplasm by 14-3-3-Mediated Translocation, J Virol, 79: 11476-11486.
doi: 10.1128/JVI.79.17.11476-11486.2005
-
Surjit M, Liu B, Chow V T, et al. 2006. The Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus Inhibits the Activity of Cyclin-Cyclin-dependent Kinase Complex and Blocks S Phase Progression in Mammalian Cells. J Biol Chem, 281: 10669-10681.
doi: 10.1074/jbc.M509233200
-
Wei W J, Wen H Y. 2007. The role of Chemokine CXCL16 in clinic diseases. Prog Modern Biomed, 7 (5): 798-800. (in Chinese).
-
Wilbanks A, Zondlo S C, Murphy K, et al. 2001. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol, 166 (8): 5145-5154.
doi: 10.4049/jimmunol.166.8.5145
-
Zhao X G, Nicholls J M, Chen Y G. 2007. Sars-cov nucleocapsid protein interacts with smad3 and modulates TGF-β signaling. J Biol Chem, 283: 3272-3280.